首页> 美国卫生研究院文献>World Journal of Gastroenterology >A nested case-control study of maternal-neonatal transmission of hepatitis B virus in a Chinese population
【2h】

A nested case-control study of maternal-neonatal transmission of hepatitis B virus in a Chinese population

机译:乙型肝炎病毒母婴传播的巢式病例对照研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: To examine the determinants of maternal-neonatal transmission of hepatitis B virus (HBV).METHODS: A nested case-control study was conducted in Changsha, Hunan, People’s Republic of China from January 1, 2005 to September 31, 2006. To avoid potential maternal blood contamination, we collected vein blood of newborns immediately after birth and before initial hepatitis B vaccination to determine the HBV infection status of the newborn. For each HBsAg-positive infant, one HBsAg-negative infant born to an HBsAg-positive mother was matched by hospital at birth (same), gender (same), and date of birth (within 1 mo). A face-to-face interview was conducted to collect clinical and epidemiological data. Conditional logistic regression analysis was used to estimate the independent effects of various determinants on maternal-neonatal transmission of HBV.RESULTS: A total of 141 HBsAg-positive infants and 141 individually matched HBsAg-negative infants were included in the final analysis. Maternal first-degree family history of HBV infection, intrahepatic cholestasis, and premature rupture of membranes were risk factors for perinatal transmission of HBV, whereas systematic treatment and HBV immunoglobulin injections for mothers with HBV infection were protective factors for maternal-neonatal transmission of HBV, after adjustment for potential confounding factors.CONCLUSION: For HBsAg-positive mothers, systematic treatment, HBV immunoglobulin administration, and controlling intrahepatic cholestasis and pregnancy complications may reduce the incidence of perinatal transmission of HBV.
机译:目的:研究决定乙型肝炎病毒(HBV)母婴传播的因素。方法:2005年1月1日至2006年9月31日在中国湖南长沙进行了一项嵌套的病例对照研究。为了避免潜在的母体血液污染,我们在出生后和初次接种乙肝疫苗之前立即收集了新生儿的静脉血,以确定新生儿的HBV感染状况。对于每个HBsAg阳性婴儿,一名HBsAg阳性母亲出生的HBsAg阴性婴儿在出生时(相同),性别(相同)和出生日期(1个月以内)与医院相匹配。进行了面对面的采访,以收集临床和流行病学数据。结果采用条件对数回归分析来评估各种决定因素对乙肝母婴传播的独立影响。结果:最终分析共纳入141名HBsAg阳性婴儿和141名单独配对的HBsAg阴性婴儿。孕产妇一级HBV感染家族史,肝内胆汁淤积和胎膜早破是围产期HBV传播的危险因素,而系统治疗和HBV感染母亲注射HBV免疫球蛋白是孕产妇向新生儿HBV传播的保护因素,结论:对于HBsAg阳性的母亲,系统治疗,给予HBV免疫球蛋白,控制肝内胆汁淤积和妊娠并发症可以降低围产期HBV传播的发生率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号